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Abstract
Background: Animal studies are pivotal in allowing experimentation to identify efficacious treatment protocols for
resolution of peri-implantitis. The purpose of this investigation was to characterize an expedited dog peri-implantitis
model clinically, radiographically, and microbiologically.
Methods: Eight hound dogs underwent extractions (week 0) and implant (3.3 × 8.5 mm) placement with
simultaneous surgical defect creation and ligature placement for induction of peri-implantitis (week 10). Ligatures
were replaced at 6 weeks (week 16) and removed after 9 weeks (week 19) when supporting bone loss involved
approximately 50% of the peri-implant bone. Microbial samples from the defects and healthy control implant sites
collected at week 19 were analyzed utilizing a microarray. Clinical measures of inflammation were obtained and
radiographic bone loss was measured from periapical radiographs. Radiographic depth and width measurements of
bony defect were repeated at weeks 10 (baseline), 16, and 19. Canonical analysis of principal coordinates was used
to visualize overall differences in microbial abundance between peri-implantitis and healthy implants.
Results: This accelerated disease protocol led to intrabony defect creation with a mean depth and width of 4.3 mm
and 3.5 mm, respectively after 9 weeks of ligature placement. Microbial identification revealed 59 total bacteria in
peri-implant sites, 21 of which were only present in peri-implant sites as compared to healthy controls. Overall
microbial beta diversity (microbial between-sample compositional diversity) differed between peri-implantitis and
healthy implants (p = 0.009).
Conclusions: Within the limitations of this study, this protocol led to expedited generation of peri-implant defects
with a microbial profile indicative of a shift to disease and defect patterns conducive to regenerative treatment.
However, the possibility of potential spontaneous resolution of lesions due to the lack of a chronicity interval as
compared to chronic disease models need to be further clarified and considered during preclinical peri-implantitis
model selection.
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Background
Peri-implantitis is a bacterially induced inflammatory
disease that affects functional implants. It is character-
ized by inflammation of the peri-implant mucosa and
loss of supporting bone [1, 2]. The reported prevalence
of peri-implantitis in the literature varies with studies
reporting prevalence rates as low as 13% over an average
of five and a half years of follow-up (187 patients) [3] up
to 43% depending on the definition of disease [4]. As
peri-implantitis may lead to implant failure, clinical
researchers are interested in efforts to identify an appro-
priate treatment for peri-implantitis. Even though many
approaches for treating peri-implantitis have been inves-
tigated, the consensus is that the most efficacious treat-
ment modality has not yet been identified [5–8].
When reviewing the limited number of interventions
that have shown positive results in controlling peri-
implant inflammation, a clinical question arises: what is
the true outcome of treatment? Ideally, treatment of
peri-implantitis should lead to regeneration of the peri-
implant bone that is in direct contact with the previously
contaminated implant surface [9]. The term “re-osseoin-
tegration” has been coined to characterize true regener-
ation in the treatment of peri-implantitis [10]. It is
reasonable to assume that the true outcome of peri-
implant disease treatment studies should be bone-to-
implant contact [11, 12]. Yet, due to ethical limita-
tions, surrogates such as probing depths and/or per-
implant attachment levels have to be utilized in
human studies [7, 13]. Alternatively, the design of
animal studies could allow the retrieval of histological
cores for microscopy [14, 15].
Indeed animal studies have provided significant
knowledge on the patterns of healing following peri-
implantitis treatment and have also shown that radio-
graphic bone fill and attachment loss may be inappropri-
ate surrogates for re-osseointegration [9, 15]. Albeit
their paramount significance, recently there has been a
paucity of adequately powered animal studies to investi-
gate the true outcome of peri-implantitis interventions.
The high cost inherent to animal studies is undoubtedly
an impeding factor for prospective researchers. Funding
agencies and corporate sponsors award limited funds for
research and in many instances human studies may be
less costly alternatives. In comparison to human studies,
animal studies bare additional costs for defect creation
and healing time to better simulate human clinical con-
ditions. The time required for “natural progression” [16]
of peri-implant bone loss around induced peri-implant
defects in animal models vastly increases the animal
feeding and housing costs as well as surgical costs and
maintenance personnel fees.
Therefore, the purpose of this investigation was to
characterize an expedited dog peri-implantitis model
clinically, radiographically, and microbiologically utiliz-
ing Human Oral Microbe Identification Microarray
(HOMIM).
Methods
The study protocol (#1010A91692) for this study was
approved by the Institutional Animal Care and Use
Committee at the University of Minnesota. Animals
were obtained through University of Minnesota Research
Animal Resources (RAR). Animals were housed in RAR
facilities and all surgeries were carried out at the surgical
suites of Experimental Surgical Services of University of
Minnesota. The University of Minnesota RAR adheres
to the principles as stated in the Guide for the Care and
Use of Laboratory Animals, National Academy Press,
2010. Study was carried out from February of 2011 and
ended in June of 2012. Eight 1-year-old male Hound
dogs with weights ranging from 25 to 33 kg underwent
extractions, implant placement and ligature placement
for induction of peri-implantitis utilizing an expedited
approach. The schematic outline of the experiment is
shown in Fig. 1.
Defect generation
Experimental Surgical Services team of University of
Minnesota prepared animals, induced and monitored
anesthesia, and was in charge of recovery following their
protocols. All dogs received a prophylactic antibiotic
(Ceftiofur, 3 mg/kg IM) the evening before each early
morning surgery for tooth extraction at baseline (W0)
and implant placement after 10-week extraction healing
(W10). A sedative (Acepromazine, 0.2 mg/kg IM) and
analgesic (Buprenorphine 0.02 mg/kg IM) were adminis-
tered before the induction of anesthesia. General
anesthesia was induced by administering Propofol (2–6
mg/kg IV) and was maintained with Oxygen (2–4 L/
min) and Isoflurane (1–3%). Four teeth in the mandible
(left and right P4 and M1; 40 mm mesiodistal space in
average) and two teeth in the maxilla (left and right P4;
22 mm in average) were extracted in each dog.
Ten weeks after extractions (W10), a total of 10
identical 3.3 × 8.5 mm self-threading endosseous dental
implants (PESF3308R, Dio Corp., Busan, Korea) with re-
sorbable blast media (RBM) surfaces were placed in the
mandible and maxilla of each dog. Four 3.3-mm diam-
eter implants were placed in the maxilla. One implant
was self-threaded in a 2.8/2.4 mm diameter osteotomy
utilizing standard surgical protocol and served as
“Healthy Implant control group (HI group)” and the
remaining three implants were placed for a separate
experiment (data not included). Si× 3.3 mm diameter im-
plants were placed in the mandible in sites simulating
peri-implantitis defects and designated as “Peri-Implan-
titis Implant group (PI group)”. The defects were created
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in two steps. In the first step, an osteotomy was pre-
pared in the dog’s mandible per routine surgical protocol
for the placement of a 3.3 × 8.5 mm implant utilizing a
2.8/2.4 mm final drill. Subsequently, the coronal 3.5 mm
of the osteotomy were prepared with a 4.8 mm drill to
facilitate the peri-implant defect formation. At the end
of the preparation the implants were self-threaded with
direct bone contact at the apical 5 mm of the osteotomy,
while the coronal 3.5 mm had a 0.75 mm moat around
the 3.3 mm diameter implant (Fig. 2).
Healing abutments (5 mm height) were connected to
all maxillary and mandibular implants according to a
one-stage implant protocol (non-submerged healing).
Ligatures (Ultrapak™, Ultradent Products, Inc., South
Jordan, UT) were placed simultaneously with the im-
plant surgery and left in the defects to facilitate plaque
accumulation and peri-implantitis induction in the
coronal part of the implants while the apical 5 mm of
implant were to achieve osseointegration from self-
threading. Ligatures were replaced once at 16-week
(W16), six weeks after the implant placement surgery
and clinical pictures and radiographs were taken to
monitor bony defect development. The new replacement
ligatures were left in situ until week 19 (W19) so that
significant bony defects (40–60% bone loss) were created
to resemble defects encountered in advanced peri-
implantitis cases [17].
Nine weeks after implant surgery (W19), all ligatures
were removed and subgingival plaque samples were ob-
tained from each implant for HOMIM. Clinical pictures
and radiographs were obtained and bleeding on probing
(BoP) was measured as an index of active peri-implant
inflammation (Fig. 3). Following flap reflection, the
configuration of the peri-implant defects was evaluated
and clinical photographs were obtained. At this time
interval peri-implantitis intervention surgeries were
carried out for another research project (results not
reported). Dogs were euthanized at weeks 23, 27, 31,
and 71. A sedative (Acepromazine, 0.2 mg/kg IM) was
given before the induction of anesthesia. Anesthesia was
induced by administering 2–6 mg/kg Propofol IV to
effect. Finally, Beuthanasia D solution 40 mg/kg IV was
given for euthanasia.
Evaluation
Clinical evaluation was performed at W19 after ligature
removal. Bleeding on probing (BoP) was utilized to
assess active peri-implant inflammation. Briefly, a
periodontal probe (UNC-15) was utilized to probe the
peri-implant defects circumferentially and bleeding on
probing was assessed at 6 sites per implant as a
dichotomous variable (i.e. bleeding, not bleeding). The
configuration of defects after flap reflection was
evaluated by an experienced examiner as horizontal,
1-wall, 2-wall, 3-wall, circumferential [18].
Radiographic evaluation was performed utilizing
digital intra-oral radiographs (CDR, Schick technologies
Inc., Long Beach, CA) that were obtained with a
portable dental X-ray machine with the aid of an x-ray
alignment device (XCP, Linn Dentsply, Elgin, IL) and the
long-cone paralleling technique. The radiographs were
further analysed to measure the defect size change
Fig. 1 Schematic outline of the experiment
Fig. 2 Illustration of the simulated peri-implantitis defect design
(4.8 mm in diameter × 3.5 mm in depth) for 3.3 × 8.5 mm implant
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around the implants at W10, W16 and W19, by measur-
ing defect depth and width. Defect depth was defined as
the linear distance from the implant platform to the
depth of the peri-implant defect and width was defined
as the linear distance from the threads of implant to the
furthest edge of the defect (Fig. 4). All measurements
were performed twice at 2 separate time points by a
calibrated examiner using a specialized software that
allowed use of the implant length as internal reference
(ImageJ, NIH, Bethesda, MD). Intra-class correlation co-
efficient (ICC) was calculated to assess the examiner’s
reliability between the two measurements.
Microbial sampling was performed using sterile plastic
implant scalers. DNA was extracted from all samples
using the recommended HOMIM protocol http://mim.
forsyth.org) (on the day of collection. DNA extracts were
frozen at − 80 °C and shipped to the HOMIM analysis
core at the Forsyth Dental Center (Boston, MA). A
detailed description of the HOMIM protocol
including PCR primers, thermal cycling conditions,
labelling, hybridization and normalization has been
published previously [19]. The HOMIM arrays pro-
duce relative intensity values ranging from 0 to 5 (the
minimum threshold for signal detection is equivalent
to approx. 104 bacterial cells) [19]. This number pro-
vided a semi-quantitative estimate of the relative
abundance of rDNA within each sample that hybrid-
ized with each probe.
Statistical analyses
All analyses for radiographic bony defect sizes were per-
formed with the SAS system (v. 9.3; SAS Institute, Cary,
NC) and R version 3.5.2 (R Foundation for Statistical
Computing, Vienna, Austria). The defect depth, defect
width and defect depth percentage (defect depth/implant
length 8.5 mm × 100) were summarized as mean ± SD at
each time point for each group. The p-values for
comparison of PI and HI groups at W16 and W19 were
calculated from linear mixed models to account for
within cluster correlation with dog considered as a ran-
dom factor. Mixed-effects models were also employed to
investigate the time effect among PI groups for defect
depth, defect width and defect depth percentage. The
estimated means ±SE were reported. Canonical analysis
of principal coordinates (CAP) [20] was used to visualize
overall differences in microbial between-sample compos-
itional diversity (i.e. beta diversity) between peri-
implantitis and healthy implants. Implant status (peri-
implantitis or healthy) was used as the constraint
variable, and the association of microbial abundance and
implant status was assessed using permutation testing,
by permuting the implant status labels 1000 times and
calculating the proportion of permutations where the
Fig. 3 Clinical photographs and representative radiograph of the elicited defects taken at Week-19
Fig. 4 Vertical (depth, black arrows) and horizontal (width, white
arrows) defect measurements
Seong et al. BMC Oral Health          (2019) 19:150 Page 4 of 11
Ta
b
le
1
D
es
cr
ip
tiv
e
st
at
is
tic
s
on
de
fe
ct
de
pt
h,
de
fe
ct
de
pt
h
ra
tio
,d
ef
ec
t
w
id
th
an
d
P-
va
lu
es
be
tw
ee
n
H
ea
lth
y
Im
pl
an
t
an
d
Pe
ri-
Im
pl
an
tit
is
im
pl
an
t
gr
ou
ps
W
ee
k
St
at
s
H
ea
lth
y
Im
pl
an
t
(n
=
7)
Pe
ri-
Im
pl
an
tit
is
Im
pl
an
t
(n
=
42
)
P-
va
lu
es
D
ef
ec
t
D
ep
th
(m
m
)
D
ef
ec
t
W
id
th
(m
m
)
D
ef
ec
t
D
ep
th
%
D
ef
ec
t
D
ep
th
(m
m
)
D
ef
ec
t
W
id
th
(m
m
)
D
ef
ec
t
D
ep
th
%
D
ef
ec
t
D
ep
th
(m
m
)
D
ef
ec
t
W
id
th
(m
m
)
D
ef
ec
t
D
ep
th
%
W
10
n
7
7
7
40
37
40
M
ed
ia
n
0
0
0
2.
80
0.
63
32
.9
1
M
ea
n
(S
D
)
0
0
0
2.
77
(0
.5
3)
0.
62
(0
.0
9)
32
.5
9
(6
.2
5)
(M
in
,M
ax
)
(0
,0
)
(0
,0
)
(0
,0
)
(1
.7
3,
3.
81
)
(0
.4
2,
0.
84
)
(2
0.
29
,4
4.
82
)
Es
tim
at
e
(S
E)
0
(0
)
0
(0
)
0
(0
)
2.
78
(0
.1
7)
0.
62
(0
.0
2)
32
.7
3
(1
.9
7)
<
0.
00
1
<
0.
00
1
<
0.
00
1
W
16
n
4
3
4
42
40
42
M
ed
ia
n
0.
81
0.
52
9.
49
2.
98
2.
73
35
.0
1
M
ea
n
(S
D
)
0.
80
(0
.2
2)
0.
90
(0
.7
2)
9.
46
(2
.6
1)
3.
03
(0
.6
8)
2.
65
(1
.0
7)
36
.6
2
(8
.0
4)
(M
in
,M
ax
)
(0
.5
4,
1.
06
)
(0
.4
5,
1.
73
)
(6
.3
8,
12
.4
7)
(1
.0
1,
4.
87
)
(1
.0
9,
6.
38
)
(1
1.
82
,5
7.
24
)
Es
tim
at
e
(S
E)
0.
85
(0
.3
3)
0.
72
(0
.6
2)
9.
98
(3
.9
1)
3.
03
(0
.1
4)
2.
65
(0
.2
1)
35
.6
2
(1
.6
0)
<
0.
00
1
0.
00
4
<
0.
00
1
W
19
n
3
2
3
42
35
42
M
ed
ia
n
1.
51
0.
73
17
.7
6
4.
35
3.
57
51
.1
3
M
ea
n
(S
D
)
1.
40
(0
.4
6)
0.
73
(0
.1
8)
16
.4
2
(5
.4
1)
4.
27
(0
.6
1)
3.
51
(0
.5
4)
50
.2
6
(7
.1
9)
(M
in
,M
ax
)
(0
.8
9,
1.
79
)
(0
.6
1,
0.
86
)
(1
0.
47
,2
1.
03
)
(2
.8
4,
5.
86
)
(2
.3
8,
4.
71
)
(3
3.
44
,6
8.
97
)
Es
tim
at
e
(S
E)
1.
47
(0
.3
4)
0.
48
(0
.3
2)
17
.3
4
(3
.9
6)
4.
27
(0
.1
4)
3.
52
(0
.1
7)
50
.2
6
(1
.6
9)
<
0.
00
1
<
0.
00
1
<
0.
00
1
Seong et al. BMC Oral Health          (2019) 19:150 Page 5 of 11
prediction (of implant status by microbial abundance)
accuracy exceeded that of the non-permuted data to ob-
tain a p-value.
Results
During the extraction procedure (W0) Dog #1 passed
away due to anesthesia complication and thus was ex-
cluded from the analysis. The data from one maxillary
healthy implant (HI) as a control and 6 mandibular peri-
implantitis implants (PI) per dog were reported from
Dogs #2–8.
All implants exhibited 100% BoP at W19. Also, clinical
evaluation performed after flap elevation revealed that
this model led to the generation of circumferential bony
defects (Schwarz Class 1e) [18] in most cases.
Descriptive statistics on defect depth, defect width,
and defect depth percentage measured from radiographs
of W10, W16, and W19 are presented in Table 1. Defect
size was significantly different between HI and PI groups
at all 3 time points. Table 2 reports bony defect depth,
width, and depth percentage estimates (SE) and p-values
for the time effect. Pairwise comparison is presented in
Table 3. Both defect depth and width significantly in-
creased from the time of surgical defect creation and
ligature placement (W10) to week 16, by 0.24 mm
(p = .04) and 1.98mm (p < .001), respectively. During the
remaining three weeks from ligature replacement (W16)
through week 19, a highly significant increase in defect
depth and width was noted, 1.24 mm (p < .001) and 0.89
mm (p < .001), respectively (Figs. 5 and 6). Intra-
correlation coefficient (ICC) assessing the reliability of
two separate time defect measurements ranged from
0.77 to 0.95 (Table 4). The 100% of the repeat measure-
ments were within 1 mm of the initial measurements.
Microbial identification results per group (PI and HI)
are presented in Fig. 7. There were 59 total bacterial taxa
and 21 of them were present only in the PI group, while
only 4 were present only in the HI group. Table 5 lists
the 21 oral taxa that were unique to the PI group, which
indicates a shift in the composition of the submucosal
microflora in peri-implantitis implant sites as compared
to healthy implant sites. Canonical analysis of principal
coordinates (CAP) comparing microbial abundances
across all HOMIM probes between peri-implantitis and
healthy implants indicated that implant status was
significantly associated with microbial composition
(p = .009) (Fig. 8).
Discussion
In the present study we explored the utilization of an ex-
pedited in vivo model for the generation of peri-implant
defects. The proposed model was an acute trauma
model that consistently led to the formation of intrabony
defects (1e according to Schwarz’s classification [18])
with a mean depth and width of 4.3 mm and 3.5 mm, re-
spectively, after 9 weeks of ligature placement. These de-
fects accounted for approximately 50% of the total
implant length. The fundamental difference between this
expedited, acute-trauma model and previous ligature-
induced peri-implantitis models is the combination of
surgical defect creation at the time of implant placement
followed by ligature-facilitated bone loss.
In the majority of previous studies, the most com-
monly utilized approach for eliciting creation of peri-
implant bone loss around implants is based on the ori-
ginal work of Lindhe et al. that borrowed concepts from
animal models of periodontitis and implemented them
in peri-implantitis research [21]. The core of these
ligature-induced peri-implantitis models was the place-
ment of silk or cotton ligatures in the peri-implant sulci
[21, 22]. Martins et al. [16] have debated that the ligature
acts as a foreign body in the peri-implant sulcus, thus
does not accurately mimic the progression of disease in
humans [16]. To better simulate a “naturally-occurring”
model of disease progression most researchers employ
plaque accumulation periods of varying duration follow-
ing ligature removal [18]. These periods of spontaneous
progression have been found to be associated with cellu-
lar inflammatory infiltrates in the peri-implant tissues
and with crater-shaped intrabony defects resembling hu-
man periodontitis [16, 18, 22–24].
In these “spontaneous progression” models the initi-
ation of peri-implant inflammation occurs by means of
submucosal placement of a ligature [22–24]. On the
Table 2 Bony defect Estimate (SE) and p-value for time effect
Variables Estimate (SE) P-value
Week 10 Week 16 Week 19
Defect Depth (mm) 2.79 (0.15) 3.03 (0.15) 4.27 (0.15) < .001
Defect Width (mm) 0.68 (0.15) 2.65 (0.15) 3.55 (0.16) < .001
Defect Depth % 32.76 (1.73) 35.62 (1.71) 50.26 (1.71) < .001
Table 3 Pairwise comparison of different time points
Variables Difference (SE) and P-value
Week 10 vs. 16 Week 10 vs. 19 Week 16 vs. 19
Defect Depth (mm) 0.2425 (0.1154), p = .0388 1.4869 (0.1154), p < .0001 1.2444 (0.1138). p < .0001
Defect Width (mm) 1.9771 (0.1369), p < .0001 2.8690 (0.1418), p < .0001 0.8919 (0.1400), p < .0001
Defect Percentage 2.8531 (1.3581), p = .0388 17.4932 (1.3581), p < .0001 14.6401 (1.3393), p < .0001
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Fig. 5 Defect depth change (mm) of the Peri-implantitis Implant group over the time (At Week-10 baseline, 3.5 mm deep and 4.8 mm wide
defect was created surgically around 3.3 mm diameter implant leaving 0.75 mm wide moat around)
Fig. 6 Defect width change (mm) of the Peri-implantitis Implant group over the time (At Week-10 baseline, 3.5 mm deep and 4.8 mm wide defect
was created surgically around 3.3mm diameter implant leaving 0.75mm wide moat around)
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contrary, in acute disease models the defect is initiated
surgically [10, 25]. This approach, as presented in our
model, allows researchers to bypass the healing period
after implant placement that averages 13 weeks in pub-
lished studies and minimizes the active ligature-related
breakdown period to 9 weeks. In the present study, the
increase in defect depth seemed to be ligature-related,
while the change in defect width demonstrated a linear
pattern with time (Figs. 5 and 6). The event of ligature
placement and replacement had a marked effect on the
bone directly apically to the ligature (Fig. 5), but it did
not directly affect the defect width that kept progressing
linearly with time (Fig. 6). This may imply that a signifi-
cant component of ligature-associated bone loss may be
attributable to contact inflammation versus chronic.
Notably, even though the ligature was placed concur-
rently with the implant insertion in the present study,
none of the placed implants failed for a 100% implant
integration rate that verifies the feasibility of the pre-
sented technique.
Overall, when comparing the experimental time
required in our study from implant placement to forma-
tion of peri-implant defects to that in the model of
Zitzmann et al. [22], approximately 20 months of animal
stocking time were saved. That constitutes a tremendous
financial benefit of the model presented herein.
Nonetheless, the presented model has limitations that
must be weighed against the gain in animal stocking
time. The main limitation of the presented model is the
potential for spontaneous regression of the defects since
they represent acute trauma situations. Such a regression
could give inflated estimates on the outcomes of regen-
erative approaches or dilute the effect size in compara-
tive regenerative studies. On the other hand, ligature-
induced models have been extensively evaluated and
have been shown to maintain the generated defects
devoid of spontaneous regeneration following ligature
removal [22]. To compensate for the potential for spon-
taneous regression in acute disease models, the use of
appropriate control sites should be carefully planned in
the study design phase. In addition, the histopathological
features of spontaneous regression models seem to
resemble the inflammatory cell infiltrate obtained from
human biopsies [25]. On the other hand, the histopatho-
logical features of accelerated models have not been
described. After all, a direct comparison of treatment
Table 4 Intra-correlation coefficient (ICC) calculated to assess
the examiner reliability at two separate time points for
measurements
Variables ICC
Defect depth – Mesial 0.93
Defect depth – Distal 0.95
Defect width – Mesial 0.83
Defect width – Distal 0.77
Fig. 7 The intensity is dichotomized as presence (1, 2, 3, 4, and 5) and absence (0). The percent of presence is plotted by groups and bacteria
types. There are 59 bacteria in total which are either present in Peri-implantitis Implant or Healthy Implant groups
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response with a classic spontaneous progression model
is needed because it is unknown if expedited model is
going to have spontaneous healing because of the acute
infection model used.
Nonetheless, the microbial composition of the peri-
implant plaque samples in our model was characterized
utilizing a microarray that allowed the detection of more
than 200 distinct oral taxa [26]. Results showed a total
of 59 oral taxa identified in the experimental peri-
implant sulci with 21 oral taxa being unique to the peri-
implantitis implants as compared to healthy implant
controls. These included genera that are known to be as-
sociated with peri-implantitis, such as Actinomyces,
Filifactor, Propionibacterium, Prevotella, Parvimonas,
and Streptococcus [27–29]. This finding of a microbial
shift towards a peri-implant pathogenic microbiota may
indicate that despite the absence of a spontaneous
progression period, the peri-implant defects from this
model were representative of chronic human peri-
implant defects from a microbiological perspective. Al-
though HOMIM is a molecular identification approach
using 16S rRNA it is still limited in that it is not an open
ended method such as next 16S DNA sequencing
approach.
In summary, the salient point of the proposed expe-
dited model of peri-implant defects is the timeliness of
generation of an appropriately sized defect by means of
surgical facilitation of defect initiation. It was shown that
this model led to the formation of peri-implant defects
that allow testing of regenerative peri-implant protocols
with no implant failures occurring in this study. There-
fore, this model has the potential to allow researchers to
study the treatment of peri-implantitis without the cost
or time burden associated with previously reported
Table 5 Twenty one oral taxa present only in PI (Peri-implantitis
Implant) group
ID Bacteria Name
40 Filifactor alocis_ot539_AA69
3 Bacteroides heparinolyticus_ot784_X18
4 Capnocytophaga granulosa and sp. clone BB167_ot325_326_AA89
16 Haemophilus sp. clone BJ095_ot036_AA97
11 Prevotella Cluster IV_ot658_693_714_782_AA44
27 Selenomonas artemidis_ot124_X66
28 Selenomonas sputigena and sp. clone EW051a_ot143_151_K65
46 Granulicatella adiacens and elegans_ot534_596_W81
67 Actinomyces Cluster I_ot671_688_701_708_AB35
2 Bacteroides heparinolyticus_ot630_N91
8 Prevotella intermedia_ot643_AB92
9 Prevotella intermedia_ot643_AD06
17 Pseudomonas aeruginosa and otitidis and sp. clone
AZ002_ot032_536_834_AB68
25 Neisseria Cluster II_ot014_609_682_764_O45
31 Mycoplasma faucium_ot606_N40
36 Parvimonas micra_ot111_V05
38 Eubacterium [14][G-1] saburreum and Lachnospiraceae [G-1] sp.
clone BE088_ot082_494_AB50
51 Streptococcus parasanguis I and II_ot411_721_AB05
55 Fusobacterium periodontium_ot201_R20
58 Leptotrichia hofstadii_ot224_AA58
69 Propionibacterium propionicum_ot739_AB72
Fig. 8 Canonical analysis of principal coordinates (CAP) comparing microbial abundances across all HOMIM probes between Peri-implantitis
Implants and Healthy Implant groups. Axes represent first and second principal coordinates based on Euclidean dissimilarity in HOMIM probe
intensities between samples
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models. However, use of this model requires understand-
ing of its limitations; this model should be further inves-
tigated to eliminate any concerns with spontaneous
defect regeneration and to characterize the histopatho-
logical characteristics of the defects.
Conclusions
We characterized an expedited in vivo model for
induced peri-implant defects around implants to be used
in assessing peri-implantitis treatment strategies. The
microbiota associated with these defects was diverse and
included oral taxa that at least on the genus level resem-
ble oral taxa frequently encountered in human peri-
implantitis. Further, the configuration of the peri-
implant defects consistently demonstrated an intrabony
component. This acute disease model may be a cost-
and time-effective alternative to the current standard of
spontaneous progression peri-implantitis models. None-
theless, comparative studies are warranted to evaluate
the potential of this expedited approach for spontaneous
healing that may bias study results.
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